Veterinary medicines storage and distribution in Australia

We provide validated storage environments for refrigerated products at +2 °C to +8 °C, controlled room temperature at +15 °C to +25 °C, and, where required, frozen and ultra-low storage at −80 °C. These conditions help ensure veterinary medicines remain within specification and suitable for use throughout their shelf life.

From individual units and cartons through to full pallets, our facility can scale with your product range and volume. This supports routine commercial stock, product launches, clinical and post-clinical supplies, samples and contingency inventory.

HL Pharma applies the principles of Good Distribution Practice and Good Wholesaling Practice across all veterinary storage and distribution activities. We hold Victorian Department of Health licences for Schedules 2, 3, 4, 8, and 9, an Office of Drug Control licence for the import and export of controlled substances, and ISO 9001:2015 certification. Operations are governed by an electronic Quality Management System that maintains document control, training, deviations and audits for full traceability.

Our facility is monitored around the clock with access controls, security systems and a validated Warehouse Management System that supports accurate inventory management, batch and expiry tracking and audit readiness.

Our operations are supported by a fully integrated, ISO 9001:2015 compliant electronic Quality Management System (eQMS), ensuring regulatory alignment and quality control at every step.

HL Pharma supports a focused group of professional customers who need secure, compliant pharmaceutical services, storage and distribution across Australia.

Our work spans:

• Pharmaceutical and biotechnology companies seeking a trusted partner for clinical, post-clinical and managed access supply.
• Clinical trial sponsors, CROs and hospital research units requiring GDP-compliant storage, cold-chain logistics and returns management for investigational products.
• Hospitals, health services, and specialist clinics need global sourcing of medicines, support for shortages and recalls, and reliable access to unregistered or speciality products.
• International manufacturers and license holders entering or supplying the Australian market who require TGA regulatory support, ODC-licensed controlled drug handling and audited local distribution.